Contractor
HAWAII BIOTECH, INC.
HONOLULU, HI
- UEI
- ECJKEEFL4L51
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$24,623,8801
Awards
1
Agencies served
1
Active from Sep 20, 2018 to Aug 6, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N93018C00023 IGF::OT::IGF - "DEVELOPMENT OF A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS." | Department of Health and Human Services | HI | Sep 20, 2018 | $24,623,880 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier ECJKEEFL4L51, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.